相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Design and Synthesis of Novel HIV-1 NNRTIs with Bicyclic Cores and with Improved Physicochemical Properties
Ladislav Prener et al.
JOURNAL OF MEDICINAL CHEMISTRY (2023)
ZBTB18 inhibits SREBP-dependent lipid synthesis by halting CTBPs and LSD1 activity in glioblastoma
Roberto Ferrarese et al.
LIFE SCIENCE ALLIANCE (2022)
Palladium-catalyzed sulfonylative coupling of benzyl(allyl) carbonates with arylsulfonyl hydrazides
Bozhen Gong et al.
GREEN SYNTHESIS AND CATALYSIS (2022)
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
Dharma Rao Tompa et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Lead Optimization: Synthesis and Biological Evaluation of PBT-1 Derivatives as Novel Antitumor Agents
Lan Xie et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
Chemical space exploration of novel naphthyl-carboxamide-diarylpyrimidine derivatives with potent anti-HIV-1 activity
Yali Sang et al.
BIOORGANIC CHEMISTRY (2021)
Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years
Chunlin Zhuang et al.
ACTA PHARMACEUTICA SINICA B (2020)
Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties
Dongwei Kang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
hERG toxicity assessment: Useful guidelines for drug design
Amanda Garrido et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV
Daniel M. Himmel et al.
PHARMACEUTICALS (2020)
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimens
Murugesan Vanangamudi et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
Robust NHC-palladacycles-catalyzed Suzuki-Miyaura cross-coupling of amides via C-N activation
Qinyue Deng et al.
GREEN SYNTHESIS AND CATALYSIS (2020)
The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic
Vigneshwaran Namasivayam et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Development of Safe Drugs: The hERG Challenge
Subha Kalyaanamoorthy et al.
MEDICINAL RESEARCH REVIEWS (2018)
Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus
Na Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing
George L. Melikian et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
The Emerging Profile of Cross-Resistance among the Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors
Nicolas Sluis-Cremer
VIRUSES-BASEL (2014)
Structural Modifications of DAPY Analogues with Potent Anti-HIV-1 Activity
Xiao-Qing Feng et al.
CHEMMEDCHEM (2009)